BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 29269154)

  • 1. Physical stability of API/polymer-blend amorphous solid dispersions.
    Lehmkemper K; Kyeremateng SO; Bartels M; Degenhardt M; Sadowski G
    Eur J Pharm Biopharm; 2018 Mar; 124():147-157. PubMed ID: 29269154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Polymer Type and Relative Humidity on the Long-Term Physical Stability of Amorphous Solid Dispersions.
    Lehmkemper K; Kyeremateng SO; Heinzerling O; Degenhardt M; Sadowski G
    Mol Pharm; 2017 Dec; 14(12):4374-4386. PubMed ID: 29050468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Low-Molecular-Weight Excipients on the Phase Behavior of PVPVA64 Amorphous Solid Dispersions.
    Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
    Pharm Res; 2018 Jan; 35(1):25. PubMed ID: 29305717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Physical Stability of PVP- and PVPVA-Amorphous Solid Dispersions.
    Lehmkemper K; Kyeremateng SO; Heinzerling O; Degenhardt M; Sadowski G
    Mol Pharm; 2017 Jan; 14(1):157-171. PubMed ID: 28043133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase behavior of pharmaceutically relevant polymer/solvent mixtures.
    Dohrn S; Luebbert C; Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
    Int J Pharm; 2020 Mar; 577():119065. PubMed ID: 31988034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of humidity on the phase behavior of API/polymer formulations.
    Prudic A; Ji Y; Luebbert C; Sadowski G
    Eur J Pharm Biopharm; 2015 Aug; 94():352-62. PubMed ID: 26117187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutual Impact of Phase Separation/Crystallization and Water Sorption in Amorphous Solid Dispersions.
    Luebbert C; Wessner M; Sadowski G
    Mol Pharm; 2018 Feb; 15(2):669-678. PubMed ID: 29309155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermodynamic and kinetic evaluation of the impact of polymer excipients on storage stability of amorphous itraconazole.
    Zhang S; Lee TWY; Chow AHL
    Int J Pharm; 2019 Jan; 555():394-403. PubMed ID: 30513399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of copolymer composition on the phase behavior of solid dispersions.
    Prudic A; Kleetz T; Korf M; Ji Y; Sadowski G
    Mol Pharm; 2014 Nov; 11(11):4189-98. PubMed ID: 25295846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical stability of hydroxypropyl methylcellulose-based amorphous solid dispersions: Experimental and computational study.
    Iemtsev A; Hassouna F; Mathers A; Klajmon M; Dendisová M; Malinová L; Školáková T; Fulem M
    Int J Pharm; 2020 Nov; 589():119845. PubMed ID: 32931845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.
    Purohit HS; Taylor LS
    Pharm Res; 2017 Dec; 34(12):2842-2861. PubMed ID: 28956218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Release and Nanodroplet Formation from Amorphous Solid Dispersions: Insight into the Roles of Drug Physicochemical Properties and Polymer Selection.
    Yang R; Mann AKP; Van Duong T; Ormes JD; Okoh GA; Hermans A; Taylor LS
    Mol Pharm; 2021 May; 18(5):2066-2081. PubMed ID: 33784104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solvent influence on the phase behavior and glass transition of Amorphous Solid Dispersions.
    Dohrn S; Luebbert C; Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
    Eur J Pharm Biopharm; 2021 Jan; 158():132-142. PubMed ID: 33212185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moisture-induced phase separation and recrystallization in amorphous solid dispersions.
    Luebbert C; Sadowski G
    Int J Pharm; 2017 Oct; 532(1):635-646. PubMed ID: 28867448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermodynamic Modeling of Solvent-Impact on Phase Separation in Amorphous Solid Dispersions during Drying.
    Dohrn S; Reimer P; Luebbert C; Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
    Mol Pharm; 2020 Jul; 17(7):2721-2733. PubMed ID: 32463685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining crystalline and polymeric excipients in API solid dispersions - Opportunity or risk?
    Veith H; Wiechert F; Luebbert C; Sadowski G
    Eur J Pharm Biopharm; 2021 Jan; 158():323-335. PubMed ID: 33296719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Drug-Polymer Miscibility on Enthalpy Relaxation of Irbesartan Amorphous Solid Dispersions.
    Dalsania S; Sharma J; Munjal B; Bansal AK
    Pharm Res; 2018 Jan; 35(2):29. PubMed ID: 29368174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers.
    Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
    J Pharm Sci; 2013 Jan; 102(1):171-84. PubMed ID: 23132686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viscosity of ASDs at humid conditions.
    Wolbert F; Stecker J; Luebbert C; Sadowski G
    Eur J Pharm Biopharm; 2020 Sep; 154():387-396. PubMed ID: 32717391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Water Sorption in Rubbery and Glassy Polymers, Nifedipine, and Their ASDs.
    Grönniger B; Fritschka E; Fahrig I; Danzer A; Sadowski G
    Mol Pharm; 2023 Apr; 20(4):2194-2206. PubMed ID: 36847428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.